nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Topotecan—lung cancer	0.0583	0.142	CbGbCtD
Conivaptan—CYP3A4—Gefitinib—lung cancer	0.0533	0.13	CbGbCtD
Conivaptan—CYP3A4—Teniposide—lung cancer	0.0517	0.126	CbGbCtD
Conivaptan—CYP3A4—Vinorelbine—lung cancer	0.0411	0.1	CbGbCtD
Conivaptan—CYP3A4—Crizotinib—lung cancer	0.0327	0.0796	CbGbCtD
Conivaptan—CYP3A4—Erlotinib—lung cancer	0.0315	0.0768	CbGbCtD
Conivaptan—CYP3A4—Paclitaxel—lung cancer	0.0289	0.0703	CbGbCtD
Conivaptan—CYP3A4—Irinotecan—lung cancer	0.0285	0.0694	CbGbCtD
Conivaptan—CYP3A4—Vinblastine—lung cancer	0.0253	0.0617	CbGbCtD
Conivaptan—CYP3A4—Etoposide—lung cancer	0.0228	0.0556	CbGbCtD
Conivaptan—CYP3A4—Docetaxel—lung cancer	0.0209	0.0508	CbGbCtD
Conivaptan—CYP3A4—Doxorubicin—lung cancer	0.0156	0.0379	CbGbCtD
Conivaptan—AVPR1A—respiratory system—lung cancer	0.00507	0.357	CbGeAlD
Conivaptan—AVPR2—respiratory system—lung cancer	0.0042	0.296	CbGeAlD
Conivaptan—Atorvastatin—AHR—lung cancer	0.00394	0.387	CrCbGaD
Conivaptan—Atorvastatin—UGT1A1—lung cancer	0.00277	0.273	CrCbGaD
Conivaptan—AVPR1A—lung—lung cancer	0.00269	0.19	CbGeAlD
Conivaptan—AVPR2—lung—lung cancer	0.00223	0.157	CbGeAlD
Conivaptan—Lomitapide—ABCB1—lung cancer	0.00149	0.146	CrCbGaD
Conivaptan—Tolvaptan—ABCB1—lung cancer	0.00133	0.131	CrCbGaD
Conivaptan—Atorvastatin—ABCB1—lung cancer	0.000649	0.0638	CrCbGaD
Conivaptan—Constipation—Topotecan—lung cancer	0.00059	0.00166	CcSEcCtD
Conivaptan—Pain—Topotecan—lung cancer	0.00059	0.00166	CcSEcCtD
Conivaptan—Sepsis—Methotrexate—lung cancer	0.00059	0.00166	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Erlotinib—lung cancer	0.000589	0.00166	CcSEcCtD
Conivaptan—Infection—Vinorelbine—lung cancer	0.000586	0.00165	CcSEcCtD
Conivaptan—Feeling abnormal—Vinblastine—lung cancer	0.000585	0.00165	CcSEcCtD
Conivaptan—Constipation—Erlotinib—lung cancer	0.000583	0.00165	CcSEcCtD
Conivaptan—Pain—Erlotinib—lung cancer	0.000583	0.00165	CcSEcCtD
Conivaptan—Headache—Teniposide—lung cancer	0.000583	0.00164	CcSEcCtD
Conivaptan—Erythema—Gemcitabine—lung cancer	0.000581	0.00164	CcSEcCtD
Conivaptan—Nervous system disorder—Vinorelbine—lung cancer	0.000578	0.00163	CcSEcCtD
Conivaptan—Cardiac disorder—Cisplatin—lung cancer	0.000577	0.00163	CcSEcCtD
Conivaptan—Skin disorder—Vinorelbine—lung cancer	0.000573	0.00162	CcSEcCtD
Conivaptan—Feeling abnormal—Topotecan—lung cancer	0.000568	0.0016	CcSEcCtD
Conivaptan—Urinary tract disorder—Etoposide—lung cancer	0.000562	0.00159	CcSEcCtD
Conivaptan—Polyuria—Methotrexate—lung cancer	0.000562	0.00158	CcSEcCtD
Conivaptan—Candida infection—Doxorubicin—lung cancer	0.000562	0.00158	CcSEcCtD
Conivaptan—Mediastinal disorder—Cisplatin—lung cancer	0.00056	0.00158	CcSEcCtD
Conivaptan—Urethral disorder—Etoposide—lung cancer	0.000558	0.00157	CcSEcCtD
Conivaptan—Nausea—Teniposide—lung cancer	0.000553	0.00156	CcSEcCtD
Conivaptan—Urinary tract disorder—Paclitaxel—lung cancer	0.000551	0.00156	CcSEcCtD
Conivaptan—Hypotension—Vinorelbine—lung cancer	0.000551	0.00155	CcSEcCtD
Conivaptan—Anaemia—Irinotecan—lung cancer	0.000551	0.00155	CcSEcCtD
Conivaptan—Oedema peripheral—Paclitaxel—lung cancer	0.00055	0.00155	CcSEcCtD
Conivaptan—Urethral disorder—Paclitaxel—lung cancer	0.000547	0.00154	CcSEcCtD
Conivaptan—Body temperature increased—Topotecan—lung cancer	0.000545	0.00154	CcSEcCtD
Conivaptan—Malnutrition—Cisplatin—lung cancer	0.000541	0.00153	CcSEcCtD
Conivaptan—Erythema—Cisplatin—lung cancer	0.000541	0.00153	CcSEcCtD
Conivaptan—Body temperature increased—Erlotinib—lung cancer	0.000539	0.00152	CcSEcCtD
Conivaptan—Anaemia—Gemcitabine—lung cancer	0.000537	0.00151	CcSEcCtD
Conivaptan—Pneumonia—Docetaxel—lung cancer	0.00053	0.0015	CcSEcCtD
Conivaptan—Cardiac disorder—Etoposide—lung cancer	0.000529	0.00149	CcSEcCtD
Conivaptan—Infestation NOS—Docetaxel—lung cancer	0.000527	0.00149	CcSEcCtD
Conivaptan—Infestation—Docetaxel—lung cancer	0.000527	0.00149	CcSEcCtD
Conivaptan—Cardiac disorder—Paclitaxel—lung cancer	0.000518	0.00146	CcSEcCtD
Conivaptan—Angiopathy—Etoposide—lung cancer	0.000517	0.00146	CcSEcCtD
Conivaptan—Hypertension—Irinotecan—lung cancer	0.000515	0.00145	CcSEcCtD
Conivaptan—Mediastinal disorder—Etoposide—lung cancer	0.000513	0.00145	CcSEcCtD
Conivaptan—Sepsis—Doxorubicin—lung cancer	0.00051	0.00144	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000509	0.00144	CcSEcCtD
Conivaptan—Angiopathy—Paclitaxel—lung cancer	0.000507	0.00143	CcSEcCtD
Conivaptan—Pain—Vinorelbine—lung cancer	0.000504	0.00142	CcSEcCtD
Conivaptan—Constipation—Vinorelbine—lung cancer	0.000504	0.00142	CcSEcCtD
Conivaptan—Mediastinal disorder—Paclitaxel—lung cancer	0.000503	0.00142	CcSEcCtD
Conivaptan—Hypertension—Gemcitabine—lung cancer	0.000501	0.00141	CcSEcCtD
Conivaptan—Anaemia—Cisplatin—lung cancer	0.0005	0.00141	CcSEcCtD
Conivaptan—Phlebitis—Doxorubicin—lung cancer	0.000496	0.0014	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000491	0.00138	CcSEcCtD
Conivaptan—Confusional state—Irinotecan—lung cancer	0.00049	0.00138	CcSEcCtD
Conivaptan—Mental disorder—Paclitaxel—lung cancer	0.000489	0.00138	CcSEcCtD
Conivaptan—Pruritus—Topotecan—lung cancer	0.000488	0.00138	CcSEcCtD
Conivaptan—Malnutrition—Paclitaxel—lung cancer	0.000486	0.00137	CcSEcCtD
Conivaptan—Erythema—Paclitaxel—lung cancer	0.000486	0.00137	CcSEcCtD
Conivaptan—Feeling abnormal—Vinorelbine—lung cancer	0.000486	0.00137	CcSEcCtD
Conivaptan—Diarrhoea—Vinblastine—lung cancer	0.000486	0.00137	CcSEcCtD
Conivaptan—Infection—Irinotecan—lung cancer	0.000483	0.00136	CcSEcCtD
Conivaptan—Pruritus—Erlotinib—lung cancer	0.000483	0.00136	CcSEcCtD
Conivaptan—Nervous system disorder—Irinotecan—lung cancer	0.000477	0.00135	CcSEcCtD
Conivaptan—Diarrhoea—Topotecan—lung cancer	0.000472	0.00133	CcSEcCtD
Conivaptan—Infection—Gemcitabine—lung cancer	0.000471	0.00133	CcSEcCtD
Conivaptan—Urinary tract disorder—Docetaxel—lung cancer	0.000467	0.00132	CcSEcCtD
Conivaptan—Diarrhoea—Erlotinib—lung cancer	0.000467	0.00132	CcSEcCtD
Conivaptan—Body temperature increased—Vinorelbine—lung cancer	0.000466	0.00132	CcSEcCtD
Conivaptan—Oedema peripheral—Docetaxel—lung cancer	0.000466	0.00132	CcSEcCtD
Conivaptan—Nervous system disorder—Gemcitabine—lung cancer	0.000465	0.00131	CcSEcCtD
Conivaptan—Urethral disorder—Docetaxel—lung cancer	0.000464	0.00131	CcSEcCtD
Conivaptan—Skin disorder—Gemcitabine—lung cancer	0.00046	0.0013	CcSEcCtD
Conivaptan—Anaemia—Etoposide—lung cancer	0.000458	0.00129	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000458	0.00129	CcSEcCtD
Conivaptan—Hypotension—Irinotecan—lung cancer	0.000455	0.00128	CcSEcCtD
Conivaptan—Vomiting—Vinblastine—lung cancer	0.000451	0.00127	CcSEcCtD
Conivaptan—Anaemia—Paclitaxel—lung cancer	0.000449	0.00127	CcSEcCtD
Conivaptan—Headache—Vinblastine—lung cancer	0.000445	0.00125	CcSEcCtD
Conivaptan—Hypotension—Gemcitabine—lung cancer	0.000443	0.00125	CcSEcCtD
Conivaptan—Insomnia—Irinotecan—lung cancer	0.00044	0.00124	CcSEcCtD
Conivaptan—Cardiac disorder—Docetaxel—lung cancer	0.000439	0.00124	CcSEcCtD
Conivaptan—Infection—Cisplatin—lung cancer	0.000439	0.00124	CcSEcCtD
Conivaptan—Vomiting—Topotecan—lung cancer	0.000438	0.00124	CcSEcCtD
Conivaptan—Hypoglycaemia—Doxorubicin—lung cancer	0.000438	0.00123	CcSEcCtD
Conivaptan—Cardiac failure—Doxorubicin—lung cancer	0.000438	0.00123	CcSEcCtD
Conivaptan—Vomiting—Erlotinib—lung cancer	0.000434	0.00122	CcSEcCtD
Conivaptan—Nervous system disorder—Cisplatin—lung cancer	0.000433	0.00122	CcSEcCtD
Conivaptan—Headache—Topotecan—lung cancer	0.000432	0.00122	CcSEcCtD
Conivaptan—Angiopathy—Docetaxel—lung cancer	0.000429	0.00121	CcSEcCtD
Conivaptan—Skin disorder—Cisplatin—lung cancer	0.000429	0.00121	CcSEcCtD
Conivaptan—Hyponatraemia—Doxorubicin—lung cancer	0.000429	0.00121	CcSEcCtD
Conivaptan—Insomnia—Gemcitabine—lung cancer	0.000429	0.00121	CcSEcCtD
Conivaptan—Hypertension—Etoposide—lung cancer	0.000428	0.00121	CcSEcCtD
Conivaptan—Headache—Erlotinib—lung cancer	0.000427	0.00121	CcSEcCtD
Conivaptan—Mediastinal disorder—Docetaxel—lung cancer	0.000427	0.0012	CcSEcCtD
Conivaptan—Nausea—Vinblastine—lung cancer	0.000422	0.00119	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Irinotecan—lung cancer	0.00042	0.00118	CcSEcCtD
Conivaptan—Hypertension—Paclitaxel—lung cancer	0.00042	0.00118	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000419	0.00118	CcSEcCtD
Conivaptan—Pruritus—Vinorelbine—lung cancer	0.000417	0.00118	CcSEcCtD
Conivaptan—Constipation—Irinotecan—lung cancer	0.000416	0.00117	CcSEcCtD
Conivaptan—Pain—Irinotecan—lung cancer	0.000416	0.00117	CcSEcCtD
Conivaptan—Mental disorder—Docetaxel—lung cancer	0.000415	0.00117	CcSEcCtD
Conivaptan—Hypotension—Cisplatin—lung cancer	0.000413	0.00116	CcSEcCtD
Conivaptan—Erythema—Docetaxel—lung cancer	0.000412	0.00116	CcSEcCtD
Conivaptan—Malnutrition—Docetaxel—lung cancer	0.000412	0.00116	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000411	0.00116	CcSEcCtD
Conivaptan—Nausea—Topotecan—lung cancer	0.00041	0.00116	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000409	0.00115	CcSEcCtD
Conivaptan—Confusional state—Etoposide—lung cancer	0.000408	0.00115	CcSEcCtD
Conivaptan—Pain—Gemcitabine—lung cancer	0.000405	0.00114	CcSEcCtD
Conivaptan—Constipation—Gemcitabine—lung cancer	0.000405	0.00114	CcSEcCtD
Conivaptan—Nausea—Erlotinib—lung cancer	0.000405	0.00114	CcSEcCtD
Conivaptan—Dry mouth—Paclitaxel—lung cancer	0.000405	0.00114	CcSEcCtD
Conivaptan—Diarrhoea—Vinorelbine—lung cancer	0.000404	0.00114	CcSEcCtD
Conivaptan—Infection—Etoposide—lung cancer	0.000402	0.00113	CcSEcCtD
Conivaptan—Feeling abnormal—Irinotecan—lung cancer	0.000401	0.00113	CcSEcCtD
Conivaptan—Confusional state—Paclitaxel—lung cancer	0.0004	0.00113	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—lung cancer	0.000397	0.00112	CcSEcCtD
Conivaptan—Infection—Paclitaxel—lung cancer	0.000394	0.00111	CcSEcCtD
Conivaptan—Skin disorder—Etoposide—lung cancer	0.000393	0.00111	CcSEcCtD
Conivaptan—Feeling abnormal—Gemcitabine—lung cancer	0.00039	0.0011	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—lung cancer	0.00039	0.0011	CcSEcCtD
Conivaptan—Nervous system disorder—Paclitaxel—lung cancer	0.000389	0.0011	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—lung cancer	0.000389	0.0011	CcSEcCtD
Conivaptan—Skin disorder—Paclitaxel—lung cancer	0.000385	0.00109	CcSEcCtD
Conivaptan—Body temperature increased—Irinotecan—lung cancer	0.000385	0.00108	CcSEcCtD
Conivaptan—Pneumonia—Methotrexate—lung cancer	0.000382	0.00108	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Cisplatin—lung cancer	0.000381	0.00108	CcSEcCtD
Conivaptan—Anaemia—Docetaxel—lung cancer	0.000381	0.00107	CcSEcCtD
Conivaptan—Infestation NOS—Methotrexate—lung cancer	0.00038	0.00107	CcSEcCtD
Conivaptan—Infestation—Methotrexate—lung cancer	0.00038	0.00107	CcSEcCtD
Conivaptan—Hypotension—Etoposide—lung cancer	0.000378	0.00107	CcSEcCtD
Conivaptan—Pain—Cisplatin—lung cancer	0.000378	0.00107	CcSEcCtD
Conivaptan—Vomiting—Vinorelbine—lung cancer	0.000375	0.00106	CcSEcCtD
Conivaptan—Body temperature increased—Gemcitabine—lung cancer	0.000375	0.00106	CcSEcCtD
Conivaptan—Hypotension—Paclitaxel—lung cancer	0.000371	0.00105	CcSEcCtD
Conivaptan—Headache—Vinorelbine—lung cancer	0.00037	0.00104	CcSEcCtD
Conivaptan—Feeling abnormal—Cisplatin—lung cancer	0.000364	0.00103	CcSEcCtD
Conivaptan—Haematuria—Methotrexate—lung cancer	0.000362	0.00102	CcSEcCtD
Conivaptan—Insomnia—Paclitaxel—lung cancer	0.000359	0.00101	CcSEcCtD
Conivaptan—Hypertension—Docetaxel—lung cancer	0.000356	0.001	CcSEcCtD
Conivaptan—Nausea—Vinorelbine—lung cancer	0.00035	0.000988	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Etoposide—lung cancer	0.000349	0.000985	CcSEcCtD
Conivaptan—Body temperature increased—Cisplatin—lung cancer	0.000349	0.000985	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000348	0.000983	CcSEcCtD
Conivaptan—Pain—Etoposide—lung cancer	0.000346	0.000976	CcSEcCtD
Conivaptan—Constipation—Etoposide—lung cancer	0.000346	0.000976	CcSEcCtD
Conivaptan—Dry mouth—Docetaxel—lung cancer	0.000343	0.000968	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000343	0.000966	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—lung cancer	0.000341	0.000962	CcSEcCtD
Conivaptan—Pain—Paclitaxel—lung cancer	0.000339	0.000957	CcSEcCtD
Conivaptan—Constipation—Paclitaxel—lung cancer	0.000339	0.000957	CcSEcCtD
Conivaptan—Confusional state—Docetaxel—lung cancer	0.000339	0.000956	CcSEcCtD
Conivaptan—Urinary tract disorder—Methotrexate—lung cancer	0.000337	0.00095	CcSEcCtD
Conivaptan—Pruritus—Gemcitabine—lung cancer	0.000335	0.000946	CcSEcCtD
Conivaptan—Urethral disorder—Methotrexate—lung cancer	0.000334	0.000943	CcSEcCtD
Conivaptan—Infection—Docetaxel—lung cancer	0.000334	0.000942	CcSEcCtD
Conivaptan—Feeling abnormal—Etoposide—lung cancer	0.000333	0.000941	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—lung cancer	0.000333	0.000939	CcSEcCtD
Conivaptan—Diarrhoea—Irinotecan—lung cancer	0.000333	0.000939	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—lung cancer	0.000331	0.000934	CcSEcCtD
Conivaptan—Nervous system disorder—Docetaxel—lung cancer	0.00033	0.00093	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—lung cancer	0.000329	0.000928	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—lung cancer	0.000329	0.000928	CcSEcCtD
Conivaptan—Feeling abnormal—Paclitaxel—lung cancer	0.000327	0.000922	CcSEcCtD
Conivaptan—Skin disorder—Docetaxel—lung cancer	0.000327	0.000921	CcSEcCtD
Conivaptan—Diarrhoea—Gemcitabine—lung cancer	0.000324	0.000915	CcSEcCtD
Conivaptan—Body temperature increased—Etoposide—lung cancer	0.00032	0.000902	CcSEcCtD
Conivaptan—Urinary tract infection—Doxorubicin—lung cancer	0.00032	0.000902	CcSEcCtD
Conivaptan—Cardiac disorder—Methotrexate—lung cancer	0.000317	0.000893	CcSEcCtD
Conivaptan—Hypotension—Docetaxel—lung cancer	0.000314	0.000886	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—lung cancer	0.000314	0.000885	CcSEcCtD
Conivaptan—Body temperature increased—Paclitaxel—lung cancer	0.000314	0.000885	CcSEcCtD
Conivaptan—Angiopathy—Methotrexate—lung cancer	0.00031	0.000873	CcSEcCtD
Conivaptan—Vomiting—Irinotecan—lung cancer	0.000309	0.000872	CcSEcCtD
Conivaptan—Mediastinal disorder—Methotrexate—lung cancer	0.000307	0.000867	CcSEcCtD
Conivaptan—Headache—Irinotecan—lung cancer	0.000305	0.00086	CcSEcCtD
Conivaptan—Insomnia—Docetaxel—lung cancer	0.000304	0.000858	CcSEcCtD
Conivaptan—Diarrhoea—Cisplatin—lung cancer	0.000302	0.000852	CcSEcCtD
Conivaptan—Vomiting—Gemcitabine—lung cancer	0.000301	0.00085	CcSEcCtD
Conivaptan—Mental disorder—Methotrexate—lung cancer	0.000299	0.000843	CcSEcCtD
Conivaptan—Erythema—Methotrexate—lung cancer	0.000297	0.000838	CcSEcCtD
Conivaptan—Malnutrition—Methotrexate—lung cancer	0.000297	0.000838	CcSEcCtD
Conivaptan—Headache—Gemcitabine—lung cancer	0.000297	0.000837	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—lung cancer	0.000292	0.000823	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—lung cancer	0.000291	0.000821	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Docetaxel—lung cancer	0.00029	0.000819	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—lung cancer	0.00029	0.000817	CcSEcCtD
Conivaptan—Nausea—Irinotecan—lung cancer	0.000289	0.000815	CcSEcCtD
Conivaptan—Constipation—Docetaxel—lung cancer	0.000288	0.000811	CcSEcCtD
Conivaptan—Pain—Docetaxel—lung cancer	0.000288	0.000811	CcSEcCtD
Conivaptan—Pruritus—Etoposide—lung cancer	0.000286	0.000808	CcSEcCtD
Conivaptan—Nausea—Gemcitabine—lung cancer	0.000281	0.000794	CcSEcCtD
Conivaptan—Vomiting—Cisplatin—lung cancer	0.000281	0.000792	CcSEcCtD
Conivaptan—Pruritus—Paclitaxel—lung cancer	0.000281	0.000792	CcSEcCtD
Conivaptan—Feeling abnormal—Docetaxel—lung cancer	0.000277	0.000782	CcSEcCtD
Conivaptan—Diarrhoea—Etoposide—lung cancer	0.000277	0.000781	CcSEcCtD
Conivaptan—Anaemia—Methotrexate—lung cancer	0.000274	0.000774	CcSEcCtD
Conivaptan—Cardiac disorder—Doxorubicin—lung cancer	0.000274	0.000773	CcSEcCtD
Conivaptan—Diarrhoea—Paclitaxel—lung cancer	0.000271	0.000766	CcSEcCtD
Conivaptan—Angiopathy—Doxorubicin—lung cancer	0.000268	0.000756	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—lung cancer	0.000266	0.000751	CcSEcCtD
Conivaptan—Body temperature increased—Docetaxel—lung cancer	0.000266	0.00075	CcSEcCtD
Conivaptan—Nausea—Cisplatin—lung cancer	0.000262	0.00074	CcSEcCtD
Conivaptan—Mental disorder—Doxorubicin—lung cancer	0.000259	0.00073	CcSEcCtD
Conivaptan—Vomiting—Etoposide—lung cancer	0.000257	0.000726	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—lung cancer	0.000257	0.000725	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—lung cancer	0.000257	0.000725	CcSEcCtD
Conivaptan—Headache—Etoposide—lung cancer	0.000253	0.000715	CcSEcCtD
Conivaptan—Vomiting—Paclitaxel—lung cancer	0.000252	0.000712	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000251	0.000708	CcSEcCtD
Conivaptan—Headache—Paclitaxel—lung cancer	0.000249	0.000701	CcSEcCtD
Conivaptan—Confusional state—Methotrexate—lung cancer	0.000244	0.000689	CcSEcCtD
Conivaptan—Infection—Methotrexate—lung cancer	0.000241	0.000679	CcSEcCtD
Conivaptan—Nausea—Etoposide—lung cancer	0.00024	0.000678	CcSEcCtD
Conivaptan—Pruritus—Docetaxel—lung cancer	0.000238	0.000671	CcSEcCtD
Conivaptan—Nervous system disorder—Methotrexate—lung cancer	0.000238	0.00067	CcSEcCtD
Conivaptan—Anaemia—Doxorubicin—lung cancer	0.000238	0.00067	CcSEcCtD
Conivaptan—Nausea—Paclitaxel—lung cancer	0.000236	0.000665	CcSEcCtD
Conivaptan—Skin disorder—Methotrexate—lung cancer	0.000235	0.000664	CcSEcCtD
Conivaptan—Diarrhoea—Docetaxel—lung cancer	0.00023	0.000649	CcSEcCtD
Conivaptan—Hypotension—Methotrexate—lung cancer	0.000226	0.000639	CcSEcCtD
Conivaptan—Hypertension—Doxorubicin—lung cancer	0.000222	0.000626	CcSEcCtD
Conivaptan—Insomnia—Methotrexate—lung cancer	0.000219	0.000618	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000217	0.000613	CcSEcCtD
Conivaptan—Dry mouth—Doxorubicin—lung cancer	0.000214	0.000604	CcSEcCtD
Conivaptan—Vomiting—Docetaxel—lung cancer	0.000214	0.000603	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—lung cancer	0.000212	0.000597	CcSEcCtD
Conivaptan—Headache—Docetaxel—lung cancer	0.000211	0.000594	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methotrexate—lung cancer	0.000209	0.00059	CcSEcCtD
Conivaptan—Infection—Doxorubicin—lung cancer	0.000208	0.000588	CcSEcCtD
Conivaptan—Pain—Methotrexate—lung cancer	0.000207	0.000585	CcSEcCtD
Conivaptan—Nervous system disorder—Doxorubicin—lung cancer	0.000206	0.000581	CcSEcCtD
Conivaptan—Skin disorder—Doxorubicin—lung cancer	0.000204	0.000575	CcSEcCtD
Conivaptan—Nausea—Docetaxel—lung cancer	0.0002	0.000563	CcSEcCtD
Conivaptan—Feeling abnormal—Methotrexate—lung cancer	0.0002	0.000563	CcSEcCtD
Conivaptan—Hypotension—Doxorubicin—lung cancer	0.000196	0.000553	CcSEcCtD
Conivaptan—Body temperature increased—Methotrexate—lung cancer	0.000192	0.00054	CcSEcCtD
Conivaptan—Insomnia—Doxorubicin—lung cancer	0.00019	0.000535	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000181	0.000511	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—lung cancer	0.000179	0.000506	CcSEcCtD
Conivaptan—Pain—Doxorubicin—lung cancer	0.000179	0.000506	CcSEcCtD
Conivaptan—Feeling abnormal—Doxorubicin—lung cancer	0.000173	0.000488	CcSEcCtD
Conivaptan—Pruritus—Methotrexate—lung cancer	0.000171	0.000484	CcSEcCtD
Conivaptan—Body temperature increased—Doxorubicin—lung cancer	0.000166	0.000468	CcSEcCtD
Conivaptan—Diarrhoea—Methotrexate—lung cancer	0.000166	0.000468	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—VEGFC—lung cancer	0.000163	0.000774	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000163	0.000773	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFC—lung cancer	0.000162	0.000768	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000161	0.000766	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000156	0.000739	CbGpPWpGaD
Conivaptan—Vomiting—Methotrexate—lung cancer	0.000154	0.000435	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—ADCY1—lung cancer	0.000154	0.000731	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADCY1—lung cancer	0.000153	0.000725	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ALB—lung cancer	0.000152	0.000723	CbGpPWpGaD
Conivaptan—Headache—Methotrexate—lung cancer	0.000152	0.000428	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—PPP2R1B—lung cancer	0.00015	0.000712	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SMARCA4—lung cancer	0.00015	0.000712	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SMARCA4—lung cancer	0.000149	0.000707	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PPP2R1B—lung cancer	0.000149	0.000707	CbGpPWpGaD
Conivaptan—Pruritus—Doxorubicin—lung cancer	0.000148	0.000419	CcSEcCtD
Conivaptan—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000147	0.000698	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HSPB1—lung cancer	0.000145	0.000687	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000145	0.000687	CbGpPWpGaD
Conivaptan—Nausea—Methotrexate—lung cancer	0.000144	0.000406	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—HSPB1—lung cancer	0.000144	0.000682	CbGpPWpGaD
Conivaptan—Diarrhoea—Doxorubicin—lung cancer	0.000144	0.000405	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—PTHLH—lung cancer	0.000143	0.000679	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000143	0.000677	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTHLH—lung cancer	0.000142	0.000674	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—RAF1—lung cancer	0.000138	0.000654	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000136	0.000644	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ANXA1—lung cancer	0.000135	0.000639	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ANXA1—lung cancer	0.000134	0.000634	CbGpPWpGaD
Conivaptan—Vomiting—Doxorubicin—lung cancer	0.000133	0.000376	CcSEcCtD
Conivaptan—Headache—Doxorubicin—lung cancer	0.000131	0.000371	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—FLT1—lung cancer	0.00013	0.000619	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FLT1—lung cancer	0.000129	0.000614	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CG—lung cancer	0.000129	0.000613	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CG—lung cancer	0.000128	0.000608	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.000128	0.000606	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APP—lung cancer	0.000128	0.000605	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOTCH3—lung cancer	0.000128	0.000605	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APP—lung cancer	0.000127	0.000601	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOTCH3—lung cancer	0.000127	0.000601	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGF9—lung cancer	0.000127	0.000601	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGF9—lung cancer	0.000126	0.000596	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000125	0.000592	CbGpPWpGaD
Conivaptan—Nausea—Doxorubicin—lung cancer	0.000125	0.000352	CcSEcCtD
Conivaptan—CYP3A4—Biological oxidations—HPGDS—lung cancer	0.000123	0.000584	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—POMC—lung cancer	0.000123	0.000583	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—POMC—lung cancer	0.000122	0.000579	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JUNB—lung cancer	0.000121	0.000573	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JUNB—lung cancer	0.00012	0.000569	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTT1—lung cancer	0.000119	0.000566	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2A6—lung cancer	0.000118	0.00056	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GCLC—lung cancer	0.000118	0.00056	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CG—lung cancer	0.000117	0.000556	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CG—lung cancer	0.000116	0.000552	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CD—lung cancer	0.000114	0.000539	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CD—lung cancer	0.000113	0.000535	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—POMC—lung cancer	0.000112	0.00053	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—POMC—lung cancer	0.000111	0.000526	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STK11—lung cancer	0.00011	0.000521	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STK11—lung cancer	0.000109	0.000517	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6R—lung cancer	0.000109	0.000517	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6R—lung cancer	0.000108	0.000513	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FOXO3—lung cancer	0.000106	0.000503	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FOXO3—lung cancer	0.000105	0.000499	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MAP2K1—lung cancer	0.000104	0.000492	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CD—lung cancer	0.000103	0.000489	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MAP2K1—lung cancer	0.000103	0.000489	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CD—lung cancer	0.000102	0.000486	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000101	0.00048	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2E1—lung cancer	0.0001	0.000476	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AVP—lung cancer	9.92e-05	0.000471	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CB—lung cancer	9.89e-05	0.00047	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	9.89e-05	0.000469	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AVP—lung cancer	9.85e-05	0.000467	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CB—lung cancer	9.82e-05	0.000466	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1R—lung cancer	9.55e-05	0.000453	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCL8—lung cancer	9.51e-05	0.000451	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1R—lung cancer	9.48e-05	0.00045	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL8—lung cancer	9.44e-05	0.000448	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HES1—lung cancer	9.38e-05	0.000445	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HES1—lung cancer	9.32e-05	0.000442	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—RAF1—lung cancer	9.2e-05	0.000437	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—RAF1—lung cancer	9.14e-05	0.000434	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IL2—lung cancer	9.09e-05	0.000431	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IL2—lung cancer	9.02e-05	0.000428	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CB—lung cancer	8.98e-05	0.000426	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CB—lung cancer	8.92e-05	0.000423	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL8—lung cancer	8.63e-05	0.00041	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ERBB3—lung cancer	8.58e-05	0.000407	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCL8—lung cancer	8.57e-05	0.000407	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ERBB3—lung cancer	8.52e-05	0.000404	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTP1—lung cancer	8.27e-05	0.000393	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL2—lung cancer	8.25e-05	0.000392	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TERT—lung cancer	8.22e-05	0.00039	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL2—lung cancer	8.19e-05	0.000389	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TERT—lung cancer	8.16e-05	0.000387	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	8.16e-05	0.000387	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGFR1—lung cancer	7.98e-05	0.000379	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGFR1—lung cancer	7.93e-05	0.000376	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HIF1A—lung cancer	7.86e-05	0.000373	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HIF1A—lung cancer	7.81e-05	0.00037	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM1—lung cancer	7.6e-05	0.000361	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOA1—lung cancer	7.59e-05	0.00036	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOA1—lung cancer	7.53e-05	0.000357	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KDR—lung cancer	7.52e-05	0.000357	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	7.5e-05	0.000356	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KDR—lung cancer	7.47e-05	0.000354	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP1A1—lung cancer	7.21e-05	0.000342	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	7.11e-05	0.000337	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KIT—lung cancer	6.93e-05	0.000329	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CG—lung cancer	6.93e-05	0.000329	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APC—lung cancer	6.93e-05	0.000329	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—NRAS—lung cancer	6.93e-05	0.000329	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CG—lung cancer	6.88e-05	0.000326	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KIT—lung cancer	6.88e-05	0.000326	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APC—lung cancer	6.88e-05	0.000326	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NRAS—lung cancer	6.88e-05	0.000326	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EGF—lung cancer	6.85e-05	0.000325	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EGF—lung cancer	6.8e-05	0.000323	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MAPK3—lung cancer	6.63e-05	0.000315	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—POMC—lung cancer	6.59e-05	0.000313	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MAPK3—lung cancer	6.59e-05	0.000313	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—POMC—lung cancer	6.55e-05	0.000311	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—BRAF—lung cancer	6.51e-05	0.000309	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—BRAF—lung cancer	6.46e-05	0.000307	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6R—lung cancer	6.43e-05	0.000305	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CREBBP—lung cancer	6.42e-05	0.000305	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6R—lung cancer	6.39e-05	0.000303	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CREBBP—lung cancer	6.38e-05	0.000303	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—COL4A3BP—lung cancer	6.34e-05	0.000301	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AZIN2—lung cancer	6.34e-05	0.000301	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EGFR—lung cancer	6.31e-05	0.0003	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EGFR—lung cancer	6.27e-05	0.000297	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAP2K1—lung cancer	6.13e-05	0.000291	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CD—lung cancer	6.09e-05	0.000289	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAP2K1—lung cancer	6.09e-05	0.000289	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CD—lung cancer	6.05e-05	0.000287	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CA—lung cancer	6.03e-05	0.000286	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CA—lung cancer	5.99e-05	0.000284	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—KRAS—lung cancer	5.96e-05	0.000283	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—KRAS—lung cancer	5.92e-05	0.000281	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CA—lung cancer	5.48e-05	0.00026	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MDM2—lung cancer	5.46e-05	0.000259	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CA—lung cancer	5.44e-05	0.000258	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RAF1—lung cancer	5.44e-05	0.000258	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MDM2—lung cancer	5.42e-05	0.000257	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RAF1—lung cancer	5.4e-05	0.000256	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ATP5H—lung cancer	5.39e-05	0.000256	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ERBB2—lung cancer	5.38e-05	0.000255	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—POMC—lung cancer	5.37e-05	0.000255	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ERBB2—lung cancer	5.34e-05	0.000253	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CB—lung cancer	5.31e-05	0.000252	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MTOR—lung cancer	5.31e-05	0.000252	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MTOR—lung cancer	5.27e-05	0.00025	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CB—lung cancer	5.27e-05	0.00025	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL8—lung cancer	5.1e-05	0.000242	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HRAS—lung cancer	5.07e-05	0.00024	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL8—lung cancer	5.06e-05	0.00024	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HRAS—lung cancer	5.03e-05	0.000239	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—lung cancer	4.93e-05	0.000234	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—lung cancer	4.89e-05	0.000232	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CASP3—lung cancer	4.88e-05	0.000232	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL2—lung cancer	4.87e-05	0.000231	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—lung cancer	4.85e-05	0.00023	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CASP3—lung cancer	4.85e-05	0.00023	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL2—lung cancer	4.84e-05	0.00023	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—lung cancer	4.82e-05	0.000229	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLBD1—lung cancer	4.8e-05	0.000228	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCND1—lung cancer	4.75e-05	0.000226	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JUN—lung cancer	4.74e-05	0.000225	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCND1—lung cancer	4.72e-05	0.000224	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JUN—lung cancer	4.71e-05	0.000223	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—lung cancer	4.61e-05	0.000219	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN1A—lung cancer	4.6e-05	0.000218	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTEN—lung cancer	4.59e-05	0.000218	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—lung cancer	4.58e-05	0.000217	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDKN1A—lung cancer	4.56e-05	0.000217	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTEN—lung cancer	4.55e-05	0.000216	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—lung cancer	4.47e-05	0.000212	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—lung cancer	4.44e-05	0.000211	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSD17B10—lung cancer	4.39e-05	0.000209	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EP300—lung cancer	4.37e-05	0.000208	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EP300—lung cancer	4.34e-05	0.000206	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SRC—lung cancer	4.25e-05	0.000202	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SRC—lung cancer	4.22e-05	0.0002	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—lung cancer	4.14e-05	0.000197	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—lung cancer	4.11e-05	0.000195	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT3—lung cancer	4.1e-05	0.000195	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NRAS—lung cancer	4.09e-05	0.000194	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CKB—lung cancer	4.08e-05	0.000194	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT3—lung cancer	4.07e-05	0.000193	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NRAS—lung cancer	4.06e-05	0.000193	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK3—lung cancer	3.92e-05	0.000186	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK3—lung cancer	3.89e-05	0.000185	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM2—lung cancer	3.84e-05	0.000182	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CNDP2—lung cancer	3.84e-05	0.000182	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MYC—lung cancer	3.81e-05	0.000181	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MYC—lung cancer	3.78e-05	0.00018	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTMR3—lung cancer	3.74e-05	0.000177	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EGFR—lung cancer	3.73e-05	0.000177	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EGFR—lung cancer	3.7e-05	0.000176	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PGAM1—lung cancer	3.64e-05	0.000173	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KRAS—lung cancer	3.52e-05	0.000167	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KRAS—lung cancer	3.5e-05	0.000166	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2A7—lung cancer	3.47e-05	0.000165	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SDC4—lung cancer	3.4e-05	0.000161	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CA—lung cancer	3.24e-05	0.000154	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CA—lung cancer	3.21e-05	0.000152	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TP53—lung cancer	3.13e-05	0.000149	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TP53—lung cancer	3.11e-05	0.000147	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—RRM1—lung cancer	3.1e-05	0.000147	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTA3—lung cancer	3.1e-05	0.000147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HRAS—lung cancer	2.99e-05	0.000142	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HRAS—lung cancer	2.97e-05	0.000141	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—B4GALT5—lung cancer	2.91e-05	0.000138	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—lung cancer	2.87e-05	0.000136	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—lung cancer	2.84e-05	0.000135	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTA4—lung cancer	2.83e-05	0.000134	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTA2—lung cancer	2.76e-05	0.000131	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTA1—lung cancer	2.66e-05	0.000126	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—lung cancer	2.64e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCC3—lung cancer	2.63e-05	0.000125	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—lung cancer	2.62e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKR1C1—lung cancer	2.55e-05	0.000121	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UGT1A1—lung cancer	2.47e-05	0.000117	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GNG11—lung cancer	2.39e-05	0.000113	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDOA—lung cancer	2.27e-05	0.000108	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOA3—lung cancer	2.21e-05	0.000105	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADCY1—lung cancer	2.15e-05	0.000102	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCG2—lung cancer	2.15e-05	0.000102	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ENO2—lung cancer	2.1e-05	9.99e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HPGDS—lung cancer	2.1e-05	9.99e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.09e-05	9.92e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTT1—lung cancer	2.04e-05	9.69e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCLC—lung cancer	2.02e-05	9.57e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2A6—lung cancer	2.02e-05	9.57e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ENO1—lung cancer	1.91e-05	9.08e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2E1—lung cancer	1.72e-05	8.14e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NQO1—lung cancer	1.7e-05	8.05e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—STK11—lung cancer	1.53e-05	7.26e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTP1—lung cancer	1.41e-05	6.71e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAT—lung cancer	1.38e-05	6.53e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCB1—lung cancer	1.34e-05	6.35e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TYMS—lung cancer	1.32e-05	6.24e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM1—lung cancer	1.3e-05	6.17e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP1A1—lung cancer	1.23e-05	5.85e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ERCC2—lung cancer	1.22e-05	5.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA1—lung cancer	1.06e-05	5.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CG—lung cancer	9.65e-06	4.58e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—POMC—lung cancer	9.19e-06	4.36e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CREBBP—lung cancer	8.95e-06	4.25e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CD—lung cancer	8.49e-06	4.03e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—lung cancer	8.38e-06	3.98e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CB—lung cancer	7.4e-06	3.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—lung cancer	7.33e-06	3.48e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTEN—lung cancer	6.39e-06	3.03e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—EP300—lung cancer	6.1e-06	2.89e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CA—lung cancer	4.51e-06	2.14e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—lung cancer	3.68e-06	1.75e-05	CbGpPWpGaD
